Trial intelligence / Profile preview

Levetiracetam for Relapse Prevention in Alcohol Dependence

NCT00758277Phase 3Completed

Sponsor
Charité – Universitätsmedizin Berlin
Start
May 2007
Primary completion
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of levetiracetam in alcohol dependence, sponsored by Charité – Universitätsmedizin Berlin. Started May 2007; status: completed.

02

Drugs

levetiracetam
03

Conditions

alcohol dependence

Beyond the preview

Go deeper on NCT00758277.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00758277.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call